<p>Wedbush 分析师 Martin Fan 今天维持了对 Sana Biotechnology 的买入评级，并设定了 7.00 美元的目标价。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并通过智能投资者精选升级到市场领先者的投资组合</li>
</ul>
<p>根据 TipRanks，Fan 是一位 5 星级分析师，平均回报率为 65.9%，成功率为 69.44%。Fan 关注医疗保健行业，主要分析 Nektar Therapeutics、Sana Biotechnology 和 Oruka Therapeutics 等股票。</p>
<p>在昨天发布的一份报告中，美国银行证券也重申了对该股票的买入评级，目标价为 7.00 美元。</p>

SANA

标普生物技术 3 倍做空 - Direxion

纽交所高增长板生物技术指数 ETF - First Trust

<p>Wedbush 分析师 Martin Fan 对 Sana Biotechnology (SANA) 维持了买入评级，目标价为 7.00 美元。Fan 是一位五星级分析师，成功率为 69.44%，专注于医疗保健领域。此外，美国银行证券也重申了该股票的买入评级，目标价同样为 7.00 美元</p>

<p>Wedbush analyst Martin Fan maintained a Buy rating on Sana Biotechnology today and set a price target of $7.00.</p>
<div class="lb-trans"><p>Wedbush 分析师 Martin Fan 今天维持了对 Sana Biotechnology 的买入评级，并设定了 7.00 美元的目标价。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并通过智能投资者精选升级到市场领先者的投资组合</li>
</ul>
</div><p>According to TipRanks, Fan is a 5-star analyst with an average return of 65.9% and a 69.44% success rate. Fan covers the Healthcare sector, focusing on stocks such as Nektar Therapeutics, Sana Biotechnology, and Oruka Therapeutics.</p>
<div class="lb-trans"><p>根据 TipRanks，Fan 是一位 5 星级分析师，平均回报率为 65.9%，成功率为 69.44%。Fan 关注医疗保健行业，主要分析 Nektar Therapeutics、Sana Biotechnology 和 Oruka Therapeutics 等股票。</p>
</div><p>In a report released yesterday, Bank of America Securities also reiterated a Buy rating on the stock with a $7.00 price target.</p>
<div class="lb-trans"><p>在昨天发布的一份报告中，美国银行证券也重申了对该股票的买入评级，目标价为 7.00 美元。</p>
</div>

Sana Biotechnology (SANA) Receives a Buy from Wedbush

Tip Ranks

Sana Biotechnology

Invesco Nasdaq Biotechnology ETF

2 倍做多纳斯达克生物技术 ETF - ProShares

生物科技 ETF - VanEck Vectors

标普生物技术 3 倍做多 - Direxion

标普生物技术 ETF - SPDR

动态生物技术与基因组 ETF - Invesco

纳斯达克生物科技指数 ETF - iShares Nasdaq

医药突破 ETF - ALPS

内克塔治疗

Oruka Therapeutics

美国银行

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Sana Biotechnology (SANA) 获得了 Wedbush 的买入评级